Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$167.14 - $192.77 $213,103 - $245,781
-1,275 Reduced 49.51%
1,300 $226,000
Q3 2022

Oct 21, 2022

SELL
$148.29 - $182.55 $168,160 - $207,011
-1,134 Reduced 30.57%
2,575 $382,000
Q2 2022

Jul 28, 2022

SELL
$155.97 - $200.09 $220,385 - $282,727
-1,413 Reduced 27.59%
3,709 $638,000
Q1 2022

Apr 14, 2022

SELL
$181.39 - $234.03 $132,958 - $171,543
-733 Reduced 12.52%
5,122 $966,000
Q3 2021

Oct 14, 2021

SELL
$189.29 - $209.69 $70,037 - $77,585
-370 Reduced 5.94%
5,855 $1.14 Million
Q2 2021

Jul 23, 2021

SELL
$155.9 - $187.99 $106,012 - $127,833
-680 Reduced 9.85%
6,225 $1.16 Million
Q4 2020

Feb 04, 2021

SELL
$157.07 - $174.35 $8,481 - $9,414
-54 Reduced 0.78%
6,905 $1.14 Million
Q2 2020

Aug 03, 2020

SELL
$111.92 - $142.53 $114,718 - $146,093
-1,025 Reduced 12.84%
6,959 $954,000
Q1 2020

May 08, 2020

SELL
$92.66 - $144.94 $58,097 - $90,877
-627 Reduced 7.28%
7,984 $940,000
Q4 2019

Feb 10, 2020

SELL
$116.25 - $133.25 $14,531 - $16,656
-125 Reduced 1.43%
8,611 $1.14 Million
Q3 2019

Oct 23, 2019

SELL
$112.57 - $128.43 $112,907 - $128,815
-1,003 Reduced 10.3%
8,736 $1.09 Million
Q1 2019

Apr 22, 2019

SELL
$81.56 - $100.67 $26,507 - $32,717
-325 Reduced 3.23%
9,739 $980,000
Q4 2018

Jan 10, 2019

BUY
$79.28 - $95.27 $25,766 - $30,962
325 Added 3.34%
10,064 $921,000
Q4 2018

Jan 10, 2019

SELL
$79.28 - $95.27 $25,766 - $30,962
-325 Reduced 3.23%
9,739 $833,000
Q3 2018

Oct 17, 2018

SELL
$83.5 - $93.23 $19,789 - $22,095
-237 Reduced 2.3%
10,064 $921,000
Q2 2018

Jul 19, 2018

BUY
$79.9 - $89.2 $46,022 - $51,379
576 Added 5.92%
10,301 $878,000
Q1 2018

May 16, 2018

SELL
$71.51 - $84.69 $26,601 - $31,504
-372 Reduced 3.68%
9,725 $812,000
Q4 2017

Jan 25, 2018

SELL
$63.24 - $72.8 $10,497 - $12,084
-166 Reduced 1.62%
10,097 $727,000
Q3 2017

Oct 31, 2017

BUY
$59.73 - $65.4 $613,008 - $671,200
10,263
10,263 $654,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.